Carnosine synthase deficiency aggravates neuroinflammation in multiple sclerosis
- 27 September 2023
- journal article
- research article
- Published by Elsevier in Progress in Neurobiology
- Vol. 231, 102532
Abstract
No abstract availableKeywords
All Related Versions
This publication has 52 references indexed in Scilit:
- NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injuryBrain, 2012
- Carnosine derivatives: new multifunctional drug-like moleculesAmino Acids, 2011
- Oxidative damage in multiple sclerosis lesionsBrain, 2011
- Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune enchephalomyelitis mouseNeuroscience, 2011
- Molecular Identification of Carnosine Synthase as ATP-grasp Domain-containing Protein 1 (ATPGD1)Journal of Biological Chemistry, 2010
- Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expressionFree Radical Biology and Medicine, 2008
- PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytesBrain Research, 2006
- Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosisJournal of Neuroscience Research, 2005
- Acrolein‐sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine/acrolein adducts by electrospray ionization tandem mass spectrometryJournal of Mass Spectrometry, 2003
- Sequence Identification and Characterization of Human Carnosinase and a Closely Related Non-specific DipeptidaseJournal of Biological Chemistry, 2003